London, 03 February 2015: TechNavio, the independent tech-focused global research firm, has published a report on the Global Scar Treatment Market 2015-2019, which is expected to grow at a CAGR of 9.09 percent during the forecast period of 2014-2019.
“Manufacturers are vying with each other to increase their market share by reducing prices in the saturated markets of Europe and the US, and developing cheaper products for the comparatively nascent markets in the emerging economies, especially India and China,” says Faisal Ghaus, Vice President of TechNavio.
“The increased emphasis on the manufacture of products that treat area-specific scars has intensified the competition. These price wars have forced vendors to look for cheaper raw materials, thus affecting the overall safety and quality of the products in the market.”
Key Market Drivers
- Increased Emphasis on Beauty
- Approval of Dermal Filler Treatment
- Increased Emphasis on R&D
Key Market Trends
- Increased Use of Silicone-based Products
- Increasing Price Competition
- Growing Popularity of Natural Oils
Key Market Vendors
- Avita Medical Ltd
- CCA Industries Inc.
- Enaltus LLC
- Merz Pharmaceuticals GmbH & Co. KGaA (Merz Pharma)
- Oculus Innovative Sciences Inc.
- Pacific World Corp.
- Revitol Corp.
- Scarguard Labs LLC
- Suneva Medical
- Valeant Pharmaceuticals International Inc.
To define the market circumstances in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
